This is a competing renewal of a training grant currently in its ninth year of funding. The goals of this training program are to answer the clearly perceived national need for immediate additional involvement of physicians in research in otolaryngology and communication disorders. The end result of the program is to develop a cadre of otolaryngologist clinician investigators who are well equipped to undertake an academic career. The program consists of two components, the first involving a one and one-half year of research academic training as part of the residency training of students in otolaryngology and the second component is a one- year research training program for post-resident fellows accepted into either the Neuro-otologic or Head and Neck Fellowship Programs of this Department. The philosophy underlying this training program is that rigorous structured research training in an academic environment is fundamental to the eventual success of the trainees in an academic career. Each year four applicants will be accepted into the Otolaryngology Resident Program as academic trainees and two fellows will be accepted into the post-training segment of the program. The research training opportunities under this program are a broadly based research faculty in the communication sciences that make up the faculty of the internationally recognized Kresge Hearing Research Institute, as well as the well-established Head and Neck Oncology Research Program of the Department that includes both clinical and laboratory research components. The research faculty of the Kresge Hearing Research Institute/Department of Otolaryngology consists of 15 members and a clinical faculty of 13. All faculty are presently engaged in research projects. Research programs available to the trainees range from otologic assessment of hearing loss with behavioral techniques to molecular genetic studies of head and neck tumor cells. Areas of research concentration include: Molecular, physiological, anatomical and behavioral discipline-drive research activities in the hearing sciences; immunological and biochemical programs in cancer cell biology; clinical trials in otology and head and neck cancer; developing programs in speech pathology, sinusitis and outcomes research, upper airway and fundamental research in microvascular surgery. Since the last application, additional research programs in hair cell regeneration, autoimmune hearing loss, perilymphatic fistula, adoptive immunotherapy and the molecular genetics of apoptosis have been developed. We have added a molecular biologist faculty member and will recruit two more in the next two years. The facilities of the Department are adequate to cover this diversity of experimentation and the centrally localized basic science laboratories of the Kresge Hearing Research Institute are a major strength for the development and success of this program.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Institutional National Research Service Award (T32)
Project #
5T32DC000024-13
Application #
2668198
Study Section
Communication Disorders Review Committee (CDRC)
Project Start
1986-07-01
Project End
2001-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
13
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Otolaryngology
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Spector, Matthew E; Sacco, Assuntina G; Bellile, Emily et al. (2017) E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma. Clin Cancer Res 23:2723-2729
Schmalbach, Cecelia E; Chepeha, Douglas B; Giordano, Thomas J et al. (2004) Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130:295-302
Sisk, Elizabeth A; Bradford, Carol R; Carey, Thomas E et al. (2003) Epstein-Barr virus detected in a head and neck squamous cell carcinoma cell line derived from an immunocompromised patient. Arch Otolaryngol Head Neck Surg 129:1115-24
Brown, David J; Kim, Theresa B; Petty, Elizabeth M et al. (2003) Characterization of a stapes ankylosis family with a NOG mutation. Otol Neurotol 24:210-5
Sisk, Elizabeth A; Robertson, Erle S (2002) Clinical implications of human papillomavirus infection. Front Biosci 7:e77-84
Brown, David J; Kim, Theresa B; Petty, Elizabeth M et al. (2002) Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. Am J Hum Genet 71:618-24
Trask, Douglas K; Wolf, Gregory T; Bradford, Carol R et al. (2002) Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope 112:638-44
Rubin, A D; Hogikyan, N D; Sullivan, K et al. (2001) Remote delivery of rAAV-GFP to the rat brainstem through the recurrent laryngeal nerve. Laryngoscope 111:2041-5
Robey, T C; Eiselt, P M; Murphy, H S et al. (2000) Biodegradable external tracheal stents and their use in a rabbit tracheal reconstruction model. Laryngoscope 110:1936-42
Griffith, A J; Ji, W; Prince, M E et al. (1999) Optic, olfactory, and vestibular dysmorphogenesis in the homozygous mouse insertional mutant Tg9257. J Craniofac Genet Dev Biol 19:157-63

Showing the most recent 10 out of 20 publications